Leprosy - World Health Organization (WHO)
2023年1月27日 · Leprosy is curable and treatment in the early stages can prevent disability. Apart from the physical deformity, persons affected by leprosy also face stigmatization and discrimination. Scope of the problem. Leprosy is a neglected tropical disease (NTD) which still occurs in more than 120 countries, with more than 200 000 new cases reported ...
Leprosy (Hansen disease) - World Health Organization (WHO)
2024年9月19日 · Leprosy is a highly variable disease, affecting different people in different ways, according to their immune response. Those at one end of the spectrum, with a high level of immunity, harbour a low number of bacilli and are referred to as patients with PB leprosy. Those with many bacilli in the body are referred to as patients with MB leprosy.
Control of Neglected Tropical Diseases - World Health …
WHO recommended multidrug therapy (MDT) regimens. The Guidelines for the diagnosis, treatment and prevention of leprosy (WHO, 2018), recommends the same 3-drug regimen with rifampicin, dapsone and clofazimine for all leprosy patients, with a duration of treatment of 6 months for PB leprosy and of 12 months for MB leprosy.
A powerful cure for leprosy: inclusiveness - World Health …
2017年1月29日 · Why greater inclusivity is key to ending leprosy transmission, as well as protecting children from leprosy-related disabilities. There are many diseases medicine is yet to cure. Diabetes is one. Polio is another. Even for asthma, a respiratory disease common in both developed and developing countries, management is the only course possible.
WHO to publish first official guidelines on leprosy diagnosis ...
2018年6月28日 · Leprosy is curable. Treatment provided in the early stages of infection averts disability. Multidrug therapy is available free of charge through WHO and has been donated to all patients worldwide by Novartis since 2000 (and by The Nippon Foundation since 1995). It provides a simple yet highly effective cure for all types of leprosy.
Guidelines for the diagnosis, treatment and prevention of leprosy
2018年10月6日 · The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infectious diseases in the ministries of health (especially but not …
Leprosy in SEARO - World Health Organization (WHO)
2016年9月15日 · What is leprosy? Leprosy, also known as Hansen’s disease, is a chronic infectious disease caused by Mycobacterium leprae. The disease mainly affects the skin, the peripheral nerves, mucosal surfaces of the upper respiratory tract and the eyes. Leprosy is known to occur at all ages ranging from early infancy to very old age.
Publishing technical guidance on leprosy - World Health …
In recent years, WHO has published the following guidance documents: A guide for surveillance of antimicrobial resistance in leprosy (2017); Guidelines for the diagnosis, treatment and prevention of leprosy (2018), which was developed based on the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach; and Technical ...
Leprosy WPRO - World Health Organization (WHO)
2023年12月5日 · Leprosy is an infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus. The disease mainly affects the skin, the peripheral nerves, mucosa of the upper respiratory tract, and the eyes. Leprosy is curable and treatment in the early stages can prevent disability.
Joint Message for World Leprosy Day 2024 - World Health …
2024年1月28日 · Leprosy, or Hansen’s disease, is an infectious disease which mainly affects the skin, peripheral nerves, mucous membranes and the eyes, and can be cured using a combination of drugs called multidrug therapy (MDT); if left untreated, it can cause disability.